Insider · CIK 0001278411

Goodman Corey S

CIK 0001278411 Name as filed on the most recent filing

Filed as Goodman Corey S (61)

329 transaction lines · from 61 filings · filed 2004-11-24 to 2026-02-04 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

273 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2020-01-08 S, Open-market sale Akero Therapeutics, Inc.AKRO 311,355, disposed Open Form 4 filing 0001012975-20-000029
2020-01-07 S, Open-market sale Akero Therapeutics, Inc.AKRO 625,149, disposed Open Form 4 filing 0001012975-20-000022
2020-01-06 S, Open-market sale Akero Therapeutics, Inc.AKRO 829,381, disposed Open Form 4 filing 0001012975-20-000022
2020-01-03 S, Open-market sale Akero Therapeutics, Inc.AKRO 241,214, disposed Open Form 4 filing 0001012975-20-000013
2020-01-02 S, Open-market sale Akero Therapeutics, Inc.AKRO 458,507, disposed Open Form 4 filing 0001012975-20-000013
2019-12-31 S, Open-market sale Akero Therapeutics, Inc.AKRO 343,259, disposed Open Form 4 filing 0001012975-20-000009
2019-06-24 P, Open-market purchase Akero Therapeutics, Inc.AKRO 4,000,000, acquired Open Form 4 filing 0001012975-19-000449
2019-04-01 P, Open-market purchase Precision Biosciences IncDTIL 800,000, acquired Open Form 4 filing 0001012975-19-000254
2006-12-18 S, Open-market sale Renovis IncRNVS 5,725, disposed Open Form 4 filing 0001181431-06-070640
2006-11-20 S, Open-market sale Renovis IncRNVS 6,262, disposed Open Form 4 filing 0001181431-06-065586
2006-10-27 S, Open-market sale Renovis IncRNVS 72,676, disposed Open Form 4 filing 0001181431-06-060337
2006-10-26 S, Open-market sale Renovis IncRNVS 93,530, disposed Open Form 4 filing 0001181431-06-060337
2006-10-02 S, Open-market sale Renovis IncRNVS 9 lines 81,694, disposed Open Form 4 filing 0001181431-06-056356
2006-09-01 S, Open-market sale Renovis IncRNVS 15 lines 88,448, disposed Open Form 4 filing 0001181431-06-051217
2006-08-01 S, Open-market sale Renovis IncRNVS 19,117, disposed Open Form 4 filing 0001181431-06-044826
2006-08-01 S, Open-market sale Renovis IncRNVS 14,976, disposed Open Form 4 filing 0001181431-06-044826
2006-08-01 S, Open-market sale Renovis IncRNVS 8,505, disposed Open Form 4 filing 0001181431-06-044826
2006-08-01 S, Open-market sale Renovis IncRNVS 7,266, disposed Open Form 4 filing 0001181431-06-044826
2006-08-01 S, Open-market sale Renovis IncRNVS 3,672, disposed Open Form 4 filing 0001181431-06-044826
2006-08-01 S, Open-market sale Renovis IncRNVS 3,648, disposed Open Form 4 filing 0001181431-06-044826
2006-08-01 S, Open-market sale Renovis IncRNVS 3,636, disposed Open Form 4 filing 0001181431-06-044826
2006-08-01 S, Open-market sale Renovis IncRNVS 3,343, disposed Open Form 4 filing 0001181431-06-044826
2006-08-01 S, Open-market sale Renovis IncRNVS 2,482, disposed Open Form 4 filing 0001181431-06-044826
2006-08-01 S, Open-market sale Renovis IncRNVS 1,244, disposed Open Form 4 filing 0001181431-06-044826
2006-08-01 S, Open-market sale Renovis IncRNVS 1,240, disposed Open Form 4 filing 0001181431-06-044826
2006-08-01 S, Open-market sale Renovis IncRNVS 1,234, disposed Open Form 4 filing 0001181431-06-044826
2006-08-01 S, Open-market sale Renovis IncRNVS 1,228, disposed Open Form 4 filing 0001181431-06-044826
2006-08-01 S, Open-market sale Renovis IncRNVS 1,217, disposed Open Form 4 filing 0001181431-06-044826

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 2
  • Open-market sale 271
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. GOODMAN COREY S, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001278411

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.